Board of Directors
Sarvajit (Jit) Chakravarty, Ph.D, has twenty-five years experience in drug discovery and development in multiple therapeutic areas. He played supporting roles in the development of three marketed products, NATRECOR(Naseritde), Scios, 2001, XARELTO(Rivaroxaban), J&J, 2011, and XTANDI(Enzalutamide), Medivation, 2012. Jit is an inventor on 286 published patent applications, worldwide, including 59 issued US patents. During his time in industry, he was part of teams that delivered five clinical candidates and eighteen (GLP stage) development candidates. After leaving Medivation, where he was Senior Vice President of Discovery and Pre-clinical Research, he started SPARCBIO, a San Francisco area based startup, in 2016. He studied for his B.Sc. in Chemistry, at St. Stephen’s College, University of Delhi, Delhi, India, 1984-87;and for his Ph.D. in Organic Chemistry at New York University, New York, 1987-92.
Ram Thakkar is executive director of an India-based pharmaceutical company. The company manufactures and distributes a wide variety of generic pharmaceutical products primarily in the Indian market with modest sales in Southeast Asia and South America. Mr. Thakkar holds a B.Com degree from Delhi University.